Zobrazeno 1 - 10
of 53
pro vyhledávání: '"AL Lazaar"'
Publikováno v:
B104. COPD BIOMARKERS: WHAT CAN THEY TELL US.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c6044d0bc0f1b4e4945fa2b6cc8ab9d
https://doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a3764
https://doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a3764
Autor:
Mekontso Dessap A; Medical Intensive Care Unit, Henri Mondor Hospital, AP-HP, 94010 Creteil, France.; CARMAS Research Group, UPEC, 94010 Creteil, France.; IMRB, INSERM U 955, 94010 Creteil, France., Hanrott K; Medicines Research Centre, GlaxoSmithKline plc., Stevenage SG1 2NY, UK., Powley WM; Medicines Research Centre, GlaxoSmithKline plc., Stevenage SG1 2NY, UK., Fowler A; GlaxoSmithKline plc., Middlesex TW8 9GS, UK., Bayliffe A; Medicines Research Centre, GlaxoSmithKline plc., Stevenage SG1 2NY, UK., Bagate F; Medical Intensive Care Unit, Henri Mondor Hospital, AP-HP, 94010 Creteil, France.; CARMAS Research Group, UPEC, 94010 Creteil, France., Hall DA; Medicines Research Centre, GlaxoSmithKline plc., Stevenage SG1 2NY, UK., Lazaar AL; Discovery Medicine, Clinical Pharmacology and Experimental Medicine, GlaxoSmithKline plc., Collegeville, PA 19426, USA., Budd DC; Medicines Research Centre, GlaxoSmithKline plc., Stevenage SG1 2NY, UK., Vieillard-Baron A; Intensive Care Medicine Unit, Assistance Publique-Hôpitaux de Paris, University Hospital Ambroise Paré, 92100 Boulogne-Billancourt, France.; INSERM UMR-1018, CESP, Team Kidney and Heart, University of Versailles Saint-Quentin en Yvelines, 78280 Villejuif, France.
Publikováno v:
Journal of clinical medicine [J Clin Med] 2022 Jul 27; Vol. 11 (15). Date of Electronic Publication: 2022 Jul 27.
Autor:
Simon MA; Division of Cardiology, Department of Medicine University of California San Francisco California USA., Hanrott K; Research and Development, Medicines Research Centre GlaxoSmithKline plc. Stevenage UK., Budd DC; Research and Development, Medicines Research Centre GlaxoSmithKline plc. Stevenage UK., Torres F; UT Southwestern Medical Center Dallas Texas USA., Grünig E; Centre for Pulmonary Hypertension Thoraxklinik Heidelberg gGmbH at Heidelberg University Hospital Heidelberg Germany., Escribano-Subias P; CIBER-CV Cardiology Department, Pulmonary Hypertension Unit Hospital Universitario 12 de Octubre Madrid Spain., Meseguer ML; Lung Transplant and Pulmonary Vascular Diseases Department Hospital Universitari Vall d'Hebron Barcelona Spain., Halank M; Department of Internal Medicine I University Hospital Carl Gustav Carus Dresden Germany., Opitz C; Department of Cardiology DRK Kliniken Berlin Germany.; Department of Cardiology, University Heart Center Berlin Charité University Medicine Berlin Germany., Hall DA; Research and Development, Medicines Research Centre GlaxoSmithKline plc. Stevenage UK., Hewens D; Research and Development, Medicines Research Centre GlaxoSmithKline plc. Stevenage UK., Powley WM; Research and Development, Medicines Research Centre GlaxoSmithKline plc. Stevenage UK., Siederer S; Research and Development, Medicines Research Centre GlaxoSmithKline plc. Stevenage UK., Bayliffe A; Research and Development, Medicines Research Centre GlaxoSmithKline plc. Stevenage UK.; Marengo Therapeutics and Apple Tree Partners Cambridge Massachusetts USA., Lazaar AL; Discovery Medicine, Clinical Pharmacology and Experimental Medicine GlaxoSmithKline plc. Collegeville Pennsylvania USA., Cahn A; Research and Development, Medicines Research Centre GlaxoSmithKline plc. Stevenage UK., Rosenkranz S; Department III of Internal Medicine, Cologne Cardiovascular Research Center (CCRC) Cologne University Heart Center Cologne Germany.
Publikováno v:
Pulmonary circulation [Pulm Circ] 2022 Jan 20; Vol. 12 (1), pp. e12024. Date of Electronic Publication: 2022 Jan 20 (Print Publication: 2022).
Autor:
Hall DA; Novel Human Genetics Research Unit, Medicines Research Centre, GlaxoSmithKline Plc., Gunnels Wood Road, Stevenage, SG1 2NY, Hertfordshire, UK. david.a.hall@gsk.com., Hanrott K; Novel Human Genetics Research Unit, Medicines Research Centre, GlaxoSmithKline Plc., Gunnels Wood Road, Stevenage, SG1 2NY, Hertfordshire, UK., Badorrek P; Department of Clinical Airway Research, Fraunhofer Institute of Toxicology and Experimental Medicine, Hannover, Germany., Berliner D; Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany., Budd DC; Novel Human Genetics Research Unit, Medicines Research Centre, GlaxoSmithKline Plc., Gunnels Wood Road, Stevenage, SG1 2NY, Hertfordshire, UK., Eames R; Novel Human Genetics Research Unit, Medicines Research Centre, GlaxoSmithKline Plc., Gunnels Wood Road, Stevenage, SG1 2NY, Hertfordshire, UK., Powley WM; Novel Human Genetics Research Unit, Medicines Research Centre, GlaxoSmithKline Plc., Gunnels Wood Road, Stevenage, SG1 2NY, Hertfordshire, UK., Hewens D; Novel Human Genetics Research Unit, Medicines Research Centre, GlaxoSmithKline Plc., Gunnels Wood Road, Stevenage, SG1 2NY, Hertfordshire, UK., Siederer S; Clinical Pharmacology Modelling and Simulation, GlaxoSmithKline, Stevenage, UK., Lazaar AL; Respiratory Therapy Area Unit, Research and Development, GlaxoSmithKline, Collegeville, PA, USA., Cahn A; Novel Human Genetics Research Unit, Medicines Research Centre, GlaxoSmithKline Plc., Gunnels Wood Road, Stevenage, SG1 2NY, Hertfordshire, UK., Hohlfeld JM; Department of Clinical Airway Research, Fraunhofer Institute of Toxicology and Experimental Medicine, Hannover, Germany.; Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany.; German Center of Lung Research (BREATH), Hannover, Germany.
Publikováno v:
Pulmonary therapy [Pulm Ther] 2021 Dec; Vol. 7 (2), pp. 487-501. Date of Electronic Publication: 2021 Jun 26.
Autor:
Keir HR; Ninewells Clinical Research Centre, University of Dundee, Dundee, UK., Richardson H; Ninewells Clinical Research Centre, University of Dundee, Dundee, UK., Fillmore C; GSK R&D, Stevenage, UK., Shoemark A; Ninewells Clinical Research Centre, University of Dundee, Dundee, UK., Lazaar AL; GSK R&D, Collegeville, PA, USA., Miller BE; GSK R&D, Collegeville, PA, USA., Tal-Singer R; GSK R&D, Collegeville, PA, USA., Chalmers JD; Ninewells Clinical Research Centre, University of Dundee, Dundee, UK., Mohan D; GSK R&D, Collegeville, PA, USA.
Publikováno v:
ERJ open research [ERJ Open Res] 2020 Nov 10; Vol. 6 (4). Date of Electronic Publication: 2020 Nov 10 (Print Publication: 2020).
Autor:
Ryan J; From The James Cook University Hospital, South Tees Hospitals NHS Foundation Trust, Middlesbrough (JR), GlaxoSmithKline Research and Development, Stevenage (AIB, TJW, EM,WP, RW, AF), Centre for Experimental Medicine, Queen's University of Belfast (DFM), Regional Intensive Care Unit, Royal Victoria Hospital, Belfast (DFM), Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry (JY, GDP), Birmingham Acute Care Research Group, Institute of Inflammation and Aging, School of Clinical and Experimental Medicine, University of Birmingham (DRT, PAH), University Hospitals Birmingham, NHS Foundation Trust, Birmingham (JY, DRT, PAH, GDP), Department of Anaesthesia, Royal Victoria Hospital, Belfast (COD, MOS), Department of Medicine, University of Cambridge, Cambridge (AMV, CS), GlaxoSmithKline R&D, Stockley Park (KH), Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK (CS) and GlaxoSmithKline Research and Development, Collegeville, Pennsylvania, USA (ALL)., Bayliffe AI, McAuley DF, Yeung J, Thickett DR, Howells PA, O'Donnell C, Vassallo AM, Wright TJ, McKie E, Hardes K, Summers C, Shields MO, Powley W, Wilson R, Lazaar AL, Fowler A, Perkins GD
Publikováno v:
European journal of anaesthesiology [Eur J Anaesthesiol] 2020 Nov; Vol. 37 (11), pp. 1014-1024.
Autor:
Stott-Miller M; GSK R&D, Epidemiology: Value, Evidence and Outcomes, Uxbridge, UK., Müllerová H; AstraZeneca, Cambridge, UK., Miller B; GSK R&D, Discovery Medicine, Collegeville, PA, USA., Tabberer M; GSK R&D Patient-Centred Outcomes: Value, Evidence and Outcomes, Uxbridge, UK., El Baou C; CEBSTAT Consultancy Ltd, London, UK., Keeley T; GSK R&D Patient-Centred Outcomes: Value, Evidence and Outcomes, Uxbridge, UK., Martinez FJ; Cornell Medical College, New York, NY, USA., Han M; Division of Pulmonary and Critical Care at the University of Michigan, Ann Arbor, MI, USA., Dransfield M; Children's of Alabama, Children's Health Research Unit/University of Alabama, Birmingham, AB, USA., Hansel NN; Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD, USA., Cooper CB; David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Woodruff P; UCSF Department of Medicine, San Francisco, CA, USA., Ortega VE; Wake Forest School of Medicine, Winston Salem, NC, USA., Comellas AP; Carver College of Medicine, University of Iowa, Iowa City, IA, USA., Paine Iii R; Division of Pulmonary and Critical Care Medicine, University of Utah, Salt Lake City, UT, USA., Kanner RE; Division of Pulmonary and Critical Care Medicine, University of Utah, Salt Lake City, UT, USA., Anderson W; Division of Pulmonary Diseases and Critical Care Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Drummond MB; Division of Pulmonary Diseases and Critical Care Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Kim V; Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA., Tal-Singer R; COPD Foundation, Washington, DC, USA., Lazaar AL; GSK R&D, Discovery Medicine, Collegeville, PA, USA.
Publikováno v:
International journal of chronic obstructive pulmonary disease [Int J Chron Obstruct Pulmon Dis] 2020 Oct 13; Vol. 15, pp. 2467-2476. Date of Electronic Publication: 2020 Oct 13 (Print Publication: 2020).
Autor:
Mole S; GlaxoSmithKline, Gunnells Wood Road, Stevenage, UK. Electronic address: sarah.x.mole@gsk.com., Harry A; GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, PA, 19426, USA., Fowler A; GlaxoSmithKline, Stockley Park, West Uxbridge, Middlesex, UB11 1BT, UK., Hotee S; GlaxoSmithKline, Gunnells Wood Road, Stevenage, UK., Warburton J; GlaxoSmithKline, Gunnells Wood Road, Stevenage, UK., Waite S; GlaxoSmithKline, Stockley Park, West Uxbridge, Middlesex, UB11 1BT, UK., Beerahee M; GlaxoSmithKline, Gunnells Wood Road, Stevenage, UK., Behm DJ; GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, PA, 19426, USA., Badorrek P; Fraunhofer-Institut Fuer Toxikologie und Experimentelle Medizin [ITEM], Nikolai-Fuchs-Straße 1, 30625, Hannover, Germany., Müller M; Fraunhofer-Institut Fuer Toxikologie und Experimentelle Medizin [ITEM], Nikolai-Fuchs-Straße 1, 30625, Hannover, Germany., Faulenbach C; Fraunhofer-Institut Fuer Toxikologie und Experimentelle Medizin [ITEM], Nikolai-Fuchs-Straße 1, 30625, Hannover, Germany., Lazaar AL; GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, PA, 19426, USA., Hohlfeld JM; Fraunhofer-Institut Fuer Toxikologie und Experimentelle Medizin [ITEM], Nikolai-Fuchs-Straße 1, 30625, Hannover, Germany; Hannover Medical School and German Centre for Lung Research, Medizinische Hochschule Hannover OE6876, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Publikováno v:
Pulmonary pharmacology & therapeutics [Pulm Pharmacol Ther] 2020 Oct; Vol. 64, pp. 101977. Date of Electronic Publication: 2020 Nov 13.
Autor:
Lazaar AL; GSK, Collegeville, PA, USA. aili.l.lazaar@gsk.com., Miller BE; GSK, Collegeville, PA, USA., Donald AC; GSK, Collegeville, PA, USA., Keeley T; GSK - Stockley Park, Uxbridge, UK., Ambery C; GSK - Stockley Park, Uxbridge, UK., Russell J; GSK, Collegeville, PA, USA., Watz H; Pulmonary Research Institute Lungen Clinic Grosshansdorf, Airway Research Center North (ARCN), German Center for Lung Research (DZL) -, Grosshansdorf, Germany., Tal-Singer R; GSK, Collegeville, PA, USA.
Publikováno v:
Respiratory research [Respir Res] 2020 Jun 12; Vol. 21 (1), pp. 149. Date of Electronic Publication: 2020 Jun 12.
Autor:
Anderson BJ; Division of Pulmonary, Allergy and Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, 3400 Spruce Street, 5036 Gates Building, Philadelphia, PA, 19104, USA. brian.anderson@uphs.upenn.edu., Calfee CS; Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, USA., Liu KD; Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, USA., Reilly JP; Division of Pulmonary, Allergy and Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, 3400 Spruce Street, 5036 Gates Building, Philadelphia, PA, 19104, USA., Kangelaris KN; Division of Hospital Medicine, Department of Medicine, University of California San Francisco, San Francisco, USA., Shashaty MGS; Division of Pulmonary, Allergy and Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, 3400 Spruce Street, 5036 Gates Building, Philadelphia, PA, 19104, USA.; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA., Lazaar AL; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.; GlaxoSmithKline R&D, Brentford, UK., Bayliffe AI; GlaxoSmithKline R&D, Brentford, UK., Gallop RJ; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.; Department of Mathematics, West Chester University, West Chester, USA., Miano TA; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA., Dunn TG; Division of Pulmonary, Allergy and Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, 3400 Spruce Street, 5036 Gates Building, Philadelphia, PA, 19104, USA., Johansson E; Division of Pulmonary, Allergy and Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, 3400 Spruce Street, 5036 Gates Building, Philadelphia, PA, 19104, USA., Abbott J; Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, USA., Jauregui A; Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, USA., Deiss T; Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, USA., Vessel K; Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, USA., Belzer A; Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, USA., Zhuo H; Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, USA., Matthay MA; Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, USA., Meyer NJ; Division of Pulmonary, Allergy and Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, 3400 Spruce Street, 5036 Gates Building, Philadelphia, PA, 19104, USA., Christie JD; Division of Pulmonary, Allergy and Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, 3400 Spruce Street, 5036 Gates Building, Philadelphia, PA, 19104, USA.; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
Publikováno v:
Critical care (London, England) [Crit Care] 2019 Dec 09; Vol. 23 (1), pp. 400. Date of Electronic Publication: 2019 Dec 09.